Rene Przkora
ASO CHAIR & CLIN PROF
MD-ANESTHESIOLOGY
GRANTS
- GRANTAbbott Pain Medicine Fellowship 2026-2027Abbott Laboratories1 Jul 2026 - 30 Jun 2027
- GRANTMedtronic Pain Fellowship 2026-2027Medtronic Inc13 Apr 2026 - 30 Jun 2027
- GRANTBoston Scientific Pain Medicine Fellowship 2025-2026Boston Scientific Corporation11 Jul 2025 - 30 Jun 2026
- GRANTUniversity of Florida Multidisciplinary Comprehensive Pain Medicine Fellowship: 2025-2026Abbott Laboratories1 Jul 2025 - 30 Jun 2026
- GRANTMedtronic Pain Fellowship 2025-2026Medtronic Inc9 Jun 2025 - 30 Jun 2026
- GRANTCharacterizing the lumbar PNS and CNS of lower back pain using MRIHeermann Anesthesia Foundation, I20 Aug 2024 - 31 Aug 2027
- GRANTMoving toward individualized care to enhance outcomes in individuals with spinal cord stimulation for intractable pain.Heermann Anesthesia Foundation, I20 Aug 2024 - 31 Aug 2027
- GRANTBoston Scientific Pain Medicine Fellowship 2024-2025Boston Scientific Corporation12 Jul 2024 - 30 Jun 2025
- GRANTAbbott Pain Medicine Fellowship 2024-2025 Academic YearAbbott Laboratories1 Jul 2024 - 30 Jun 2025
- GRANTMedtronic Pain Fellowship 2024-2025Medtronic Inc1 Jun 2024 - 30 Jun 2025
- GRANTA Phase 1, Open label, Dose-ranging Study to Assess the Safety, Tolerability, Preliminary Efficacy, and Dose Effect of CFL001 Cord Blood Product in Patients with Symptomatic Sacroiliac Joint (SIJ) Syndrome - Services AgreementCord for Life26 Jan 2024 - 14 Jan 2027
- GRANTUniversity of Florida Multidisciplinary Comprehensive Pain Medicine FellowshipAbbott Laboratories1 Jul 2023 - 30 Jun 2024
- GRANTBoston Scientific Pain Medicine Fellowship 2023-2024Boston Scientific Corporation27 Jun 2023 - 30 Jun 2024
- GRANTMedtronic Pain Fellowship 2023-2024Medtronic Inc7 Apr 2023 - 30 Jun 2024
- GRANTA Phase 1, Open Label Dose-Ranging Study to Assess the Safety, Tolerability, Preliminary Efficacy, and Dose Effect of CFL001 Cord Blood Product in Patients with Symptomatic Sacroiliac Joint SyndromeCord for Life7 Mar 2023 - 6 Mar 2028
- GRANTA Multicenter, Phase 2 Study To Assess The Safety And Efficacy Of Epidural Resiniferatoxin For The Treatment Of Intractable Pain Associated With Advanced Cancer*sorrento Therapeutics12 Jul 2022 - 25 May 2024
- GRANTEN21-01, A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of 80 mg daily of NRD135S.E1 Versus Placebo in Adult and Elderly Participants with Painful Diabetic Peripheral Neuropathy (SERENDIPITY-1)National Institute of Health Ninds1 Jul 2022 - 31 Jul 2026
- GRANTBoston Scientific Pain Medicine Fellowship 2022-2023Boston Scientific Corporation22 Jun 2022 - 30 Jun 2023
- GRANTMedtronic Pain Fellowship 2022-2023Medtronic Inc13 Jun 2022 - 30 Jun 2023
- GRANTUniversity of Florida Multidisciplinary Comprehensive Pain Medicine FellowshipAbbott Laboratories11 May 2022 - 30 Jun 2023
- GRANTRadiofrequency (RF) Ablation Prospective Outcomes Study (RAPID)Boston Scientific Corporation9 Feb 2022 - 24 Jun 2024
- GRANTReal-Time and Long-Term Effects of Medical Marijuana on Older Adults: A Prospective Cohort StudyNational Institute of Health Nia2 Feb 2022 - 30 Nov 2026
- GRANTIndependent Medical Education Program Grant - Practice of NeuromodulationBoston Scientific Corporation13 Nov 2021 - 14 Nov 2021
- GRANTEN20-01: 24-Week Study To Evaluate the Safety and Efficacy of CNTX-6970 in Subjects with Moderate to Severe Knee Osteo Arthritis PainNational Institute of Health Ninds10 Aug 2021 - 31 Dec 2024
- GRANTMedtronic Pain Fellowship 2021-20221 Jul 2021 - 30 Jun 2022